MedPath

Cerebrospinal fluid metabolites as marker for the severity of progressive post-hemorrhagic ventricular dilatation in preterm infants

Conditions
10028920
hydrocephalus after cerebral bleeding
10021666
Registration Number
NL-OMON30135
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
125
Inclusion Criteria

Preterm infants (gestational age < 34 weeks) with intraventricular hemorrhage grade III and progressive post-hemorrhagic ventricular dilatation

Exclusion Criteria

congenital cerebral malformation
cerebral parenchymal hemorrhage/infarction
periventricular leucomalacia
PHVD already present at birth
infection of the CNS
metabolic disorder

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath